News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,341 Results
Type
Article (40652)
Company Profile (269)
Press Release (676414)
Multimedia
Podcasts (76)
Webinars (17)
Section
Business (204560)
Career Advice (2018)
Deals (35501)
Drug Delivery (105)
Drug Development (81304)
Employer Resources (173)
FDA (16364)
Job Trends (14929)
News (346131)
Policy (32698)
Tag
Academia (2558)
Accelerated approval (22)
Adcomms (24)
Allergies (122)
Alliances (49574)
ALS (154)
Alzheimer's disease (1617)
Antibody-drug conjugate (ADC) (259)
Approvals (16527)
Artificial intelligence (450)
Autoimmune disease (112)
Automation (33)
Bankruptcy (361)
Best Places to Work (11638)
BIOSECURE Act (20)
Biosimilars (169)
Biotechnology (176)
Bladder cancer (142)
Brain cancer (51)
Breast cancer (564)
Cancer (4310)
Cardiovascular disease (355)
Career advice (1700)
Career pathing (34)
CAR-T (260)
CDC (44)
Celiac Disease (1)
Cell therapy (677)
Cervical cancer (34)
Clinical research (68895)
Collaboration (1439)
Company closure (4)
Compensation (1021)
Complete response letters (46)
COVID-19 (2690)
CRISPR (81)
C-suite (672)
Cystic fibrosis (135)
Data (5572)
Decentralized trials (2)
Denatured (25)
Depression (110)
Diabetes (451)
Diagnostics (6593)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (210)
Drug pricing (166)
Drug shortages (28)
Duchenne muscular dystrophy (206)
Earnings (89705)
Editorial (50)
Employer branding (21)
Employer resources (151)
Events (116510)
Executive appointments (936)
FDA (19046)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1307)
Gene editing (179)
Generative AI (38)
Gene therapy (527)
GLP-1 (910)
Government (4623)
Grass and pollen (6)
Guidances (375)
Healthcare (18858)
HIV (47)
Huntington's disease (38)
IgA nephropathy (75)
Immunology and inflammation (225)
Immuno-oncology (30)
Indications (74)
Infectious disease (2929)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (100)
Intellectual property (208)
Interviews (315)
IPO (16620)
IRA (48)
Job creations (3640)
Job search strategy (1427)
Kidney cancer (15)
Labor market (79)
Layoffs (541)
Leadership (28)
Legal (7941)
Liver cancer (87)
Longevity (12)
Lung cancer (601)
Lymphoma (346)
Machine learning (37)
Management (59)
Manufacturing (654)
MASH (151)
Medical device (13679)
Medtech (13715)
Mergers & acquisitions (19831)
Metabolic disorders (1126)
Multiple sclerosis (139)
NASH (16)
Neurodegenerative disease (275)
Neuropsychiatric disorders (68)
Neuroscience (2683)
NextGen: Class of 2025 (6518)
Non-profit (4500)
Now hiring (60)
Obesity (520)
Opinion (247)
Ovarian cancer (148)
Pain (165)
Pancreatic cancer (188)
Parkinson's disease (251)
Partnered (31)
Patents (439)
Patient recruitment (380)
Peanut (53)
People (58491)
Pharmaceutical (63)
Pharmacy benefit managers (26)
Phase I (21467)
Phase II (30331)
Phase III (22604)
Pipeline (3653)
Policy (260)
Postmarket research (2564)
Preclinical (9154)
Press Release (64)
Prostate cancer (211)
Psychedelics (42)
Radiopharmaceuticals (258)
Rare diseases (694)
Real estate (5947)
Recruiting (69)
Regulatory (23855)
Reports (51)
Research institute (2371)
Resumes & cover letters (351)
Rett syndrome (22)
RNA editing (12)
RSV (73)
Schizophrenia (133)
Series A (211)
Series B (165)
Service/supplier (11)
Sickle cell disease (90)
Special edition (20)
Spinal muscular atrophy (153)
Sponsored (39)
Startups (3604)
State (2)
Stomach cancer (16)
Supply chain (96)
Tariffs (80)
The Weekly (49)
Vaccines (939)
Venture capital (71)
Weight loss (338)
Women's health (71)
Worklife (17)
Date
Today (103)
Last 7 days (602)
Last 30 days (2488)
Last 365 days (30246)
2025 (29237)
2024 (35220)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (734)
Alabama (76)
Alaska (7)
Arizona (287)
Arkansas (13)
Asia (38906)
Australia (6357)
California (10282)
Canada (3064)
China (951)
Colorado (431)
Connecticut (443)
Delaware (302)
Europe (83877)
Florida (1526)
Georgia (328)
Hawaii (2)
Idaho (61)
Illinois (771)
India (54)
Indiana (485)
Iowa (20)
Japan (357)
Kansas (122)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1303)
Massachusetts (7425)
Michigan (298)
Minnesota (578)
Mississippi (5)
Missouri (118)
Montana (30)
Nebraska (26)
Nevada (111)
New Hampshire (73)
New Jersey (2785)
New Mexico (28)
New York (2748)
North Carolina (1345)
North Dakota (8)
Northern California (4922)
Ohio (302)
Oklahoma (20)
Oregon (38)
Pennsylvania (2112)
Puerto Rico (19)
Rhode Island (45)
South America (1100)
South Carolina (58)
South Dakota (1)
Southern California (3978)
Tennessee (160)
Texas (1582)
United States (36790)
Utah (306)
Vermont (1)
Virginia (236)
Washington D.C. (78)
Washington State (838)
West Virginia (4)
Wisconsin (88)
Wyoming (2)
717,341 Results for "xyphos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PHANES THERAPEUTICS entered into a research collaboration with Xyphos Biosciences, Inc., an Astellas Company
Phanes Therapeutics, Inc. today announced that it has entered into a research collaboration with Xyphos Biosciences, Inc. an Astellas Company.
March 6, 2023
·
2 min read
Business
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Astellas Pharma Inc. and Poseida Therapeutics, Inc. today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, “Xyphos”) and Poseida have entered into a research collaboration and license agreement to develop novel convertibleCAR® programs by combining the innovative cell therapy platforms from each of the companies.
May 1, 2024
·
8 min read
Press Releases
BrYet US, Inc. Expands Patent Portfolio with New U.S. Patent for Targeted Drug Delivery
Near-term applications include combinations with kinase inhibitors (KIs) that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location
November 13, 2025
·
1 min read
Press Releases
Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications
November 26, 2025
·
2 min read
Press Releases
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
December 11, 2025
·
8 min read
Press Releases
Britannia Life Sciences Inc. Enters into $11.3 Million Share Exchange Agreement with McEwen Inc. and Britannia Mining Solutions Inc.
November 3, 2025
·
4 min read
Genetown
Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics
Astellas Pharma Inc. and Kelonia Therapeutics announced that Xyphos Biosciences, Inc., and Kelonia have entered into a research collaboration and license agreement to develop novel Immuno-Oncology therapeutics.
February 15, 2024
·
6 min read
Press Releases
Zevra Therapeutics, Inc. Announces CFO Transition
November 21, 2025
·
3 min read
Press Releases
PURE Bioscience, Inc. Announces Leadership Promotions
November 20, 2025
·
3 min read
Press Releases
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000
December 10, 2025
·
8 min read
1 of 71,735
Next
